Cargando…
Targeting macrophages in cancer immunotherapy
Immunotherapy is regarded as the most promising treatment for cancers. Various cancer immunotherapies, including adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small-molecule inhibitors, have achieved certain successes. In this review, we summarize the...
Autores principales: | Duan, Zhaojun, Luo, Yunping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994399/ https://www.ncbi.nlm.nih.gov/pubmed/33767177 http://dx.doi.org/10.1038/s41392-021-00506-6 |
Ejemplares similares
-
Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Petty, Amy J., et al.
Publicado: (2021) -
Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages
por: Reis-Sobreiro, Mariana, et al.
Publicado: (2021) -
Macrophage targeting: opening new possibilities for cancer immunotherapy
por: Cassetta, Luca, et al.
Publicado: (2018) -
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
por: Fendl, B., et al.
Publicado: (2023) -
Exosomal miRNA-223-3p derived from tumor associated macrophages promotes pulmonary metastasis of breast cancer 4T1 cells
por: Wang, Ziyuan, et al.
Publicado: (2023)